.png){kind=icon}
.png){kind=icon}
Return
Pharmacovigilance Signal Detection and Mutually Exclusive Driver Mutations of the PI3K/AKT Pathway in Breast Cancer Treated With Capivasertib
.png){kind=icon}
OA
AI
Z
Y
B
Q
W
Y
X
DOI：10.1155/humu/9532614.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
This study is aimed at comprehensively evaluating the real-world safety profile and underlying molecular mechanisms of the AKT inhibitor capivasertib by integrating pharmacovigilance data, computational biology, and multiomics analyses.
Keywords:
breast cancer
capivasertib
molecular dynamics
pharmacovigilance
single-cell RNA sequencing
tumor microenvironment
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
3.7
Papers:
5.1K
Citations:
1.3W
Organization
Cited Papers